Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The Andean Latin-American burden of diabetes attributable to high body mass index: A comparative risk assessment.

Carrillo-Larco RM, Pearson-Stuttard J, Bernabe-Ortiz A, Gregg EW.

Diabetes Res Clin Pract. 2020 Feb;160:107978. doi: 10.1016/j.diabres.2019.107978. Epub 2019 Dec 12.

2.

Multimorbidity-a defining challenge for health systems.

Pearson-Stuttard J, Ezzati M, Gregg EW.

Lancet Public Health. 2019 Dec;4(12):e599-e600. doi: 10.1016/S2468-2667(19)30222-1. No abstract available.

3.

Potential impact of diabetes prevention on mortality and future burden of dementia and disability: a modelling study.

Bandosz P, Ahmadi-Abhari S, Guzman-Castillo M, Pearson-Stuttard J, Collins B, Whittaker H, Shipley MJ, Capewell S, Brunner EJ, O'Flaherty M.

Diabetologia. 2020 Jan;63(1):104-115. doi: 10.1007/s00125-019-05015-4. Epub 2019 Nov 15.

4.

Association Between Soft Drink Consumption and Mortality in 10 European Countries.

Mullee A, Romaguera D, Pearson-Stuttard J, Viallon V, Stepien M, Freisling H, Fagherazzi G, Mancini FR, Boutron-Ruault MC, Kühn T, Kaaks R, Boeing H, Aleksandrova K, Tjønneland A, Halkjær J, Overvad K, Weiderpass E, Skeie G, Parr CL, Quirós JR, Agudo A, Sánchez MJ, Amiano P, Cirera L, Ardanaz E, Khaw KT, Tong TYN, Schmidt JA, Trichopoulou A, Martimianaki G, Karakatsani A, Palli D, Agnoli C, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, Verschuren WMM, Boer JMA, Vermeulen R, Ramne S, Sonestedt E, van Guelpen B, Holgersson PL, Tsilidis KK, Heath AK, Muller D, Riboli E, Gunter MJ, Murphy N.

JAMA Intern Med. 2019 Sep 3. doi: 10.1001/jamainternmed.2019.2478. [Epub ahead of print]

PMID:
31479109
5.

Decreasing mortality masks a growing morbidity gap in patients with heart failure.

Pearson-Stuttard J, Gregg EW.

Lancet Public Health. 2019 Aug;4(8):e365-e366. doi: 10.1016/S2468-2667(19)30132-X. No abstract available.

6.

FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.

Collins B, Kypridemos C, Pearson-Stuttard J, Huang Y, Bandosz P, Wilde P, Kersh R, Capewell S, Mozaffarian D, Whitsel LP, Micha R, O'Flaherty M; Food-PRICE Investigators.

Milbank Q. 2019 Sep;97(3):858-880. doi: 10.1111/1468-0009.12402. Epub 2019 Jul 22.

PMID:
31332837
7.

Quantifying the impact of the Public Health Responsibility Deal on salt intake, cardiovascular disease and gastric cancer burdens: interrupted time series and microsimulation study.

Laverty AA, Kypridemos C, Seferidi P, Vamos EP, Pearson-Stuttard J, Collins B, Capewell S, Mwatsama M, Cairney P, Fleming K, O'Flaherty M, Millett C.

J Epidemiol Community Health. 2019 Sep;73(9):881-887. doi: 10.1136/jech-2018-211749. Epub 2019 Jul 18.

8.

Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.

Huang Y, Kypridemos C, Liu J, Lee Y, Pearson-Stuttard J, Collins B, Bandosz P, Capewell S, Whitsel L, Wilde P, Mozaffarian D, O'Flaherty M, Micha R; Food-PRICE (Policy Review and Intervention Cost-Effectiveness) Project.

Circulation. 2019 Jun 4;139(23):2613-2624. doi: 10.1161/CIRCULATIONAHA.118.036751. Epub 2019 Apr 15.

PMID:
30982338
9.

Impacts of Brexit on fruit and vegetable intake and cardiovascular disease in England: a modelling study.

Seferidi P, Laverty AA, Pearson-Stuttard J, Bandosz P, Collins B, Guzman-Castillo M, Capewell S, O'Flaherty M, Millett C.

BMJ Open. 2019 Jan 28;9(1):e026966. doi: 10.1136/bmjopen-2018-026966.

10.

A new Health Index for England: the Chief Medical Officer's 2018 annual report.

Pearson-Stuttard J, Murphy O, Davies SC.

Lancet. 2019 Jan 5;393(10166):10-11. doi: 10.1016/S0140-6736(18)33210-0. Epub 2018 Dec 21. No abstract available.

PMID:
30581037
11.

Global patterns in excess body weight and the associated cancer burden.

Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA, Goding Sauer A, Shuval K, Gapstur SM, Jacobs EJ, Giovannucci EL, Jemal A.

CA Cancer J Clin. 2019 Mar;69(2):88-112. doi: 10.3322/caac.21499. Epub 2018 Dec 12. Review.

12.

Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: a population-based analysis of vital registration data.

Bennett JE, Pearson-Stuttard J, Kontis V, Capewell S, Wolfe I, Ezzati M.

Lancet Public Health. 2018 Dec;3(12):e586-e597. doi: 10.1016/S2468-2667(18)30214-7. Epub 2018 Nov 23.

13.

Implications of Brexit on the effectiveness of the UK soft drinks industry levy upon CHD in England: a modelling study.

Seferidi P, Laverty AA, Pearson-Stuttard J, Guzman-Castillo M, Collins B, Capewell S, O'Flaherty M, Millett C.

Public Health Nutr. 2018 Dec;21(18):3431-3439. doi: 10.1017/S1368980018002367. Epub 2018 Oct 9.

14.

Acting on non-communicable diseases in low- and middle-income tropical countries.

Ezzati M, Pearson-Stuttard J, Bennett JE, Mathers CD.

Nature. 2018 Jul;559(7715):507-516. doi: 10.1038/s41586-018-0306-9. Epub 2018 Jul 25. Review.

15.

Comparative risk assessment of school food environment policies and childhood diets, childhood obesity, and future cardiometabolic mortality in the United States.

Rosettie KL, Micha R, Cudhea F, Peñalvo JL, O'Flaherty M, Pearson-Stuttard J, Economos CD, Whitsel LP, Mozaffarian D.

PLoS One. 2018 Jul 6;13(7):e0200378. doi: 10.1371/journal.pone.0200378. eCollection 2018.

16.

Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment.

Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M.

Lancet Diabetes Endocrinol. 2018 Jun;6(6):e6-e15. doi: 10.1016/S2213-8587(18)30150-5.

17.

Reductions in national cardiometabolic mortality achievable by food price changes according to Supplemental Nutrition Assistance Program (SNAP) eligibility and participation.

Wilde PE, Conrad Z, Rehm CD, Pomeranz JL, Penalvo JL, Cudhea F, Pearson-Stuttard J, O'Flaherty M, Micha R, Mozaffarian D.

J Epidemiol Community Health. 2018 Sep;72(9):817-824. doi: 10.1136/jech-2017-210381. Epub 2018 May 10.

18.

Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.

Pearson-Stuttard J, Kypridemos C, Collins B, Mozaffarian D, Huang Y, Bandosz P, Capewell S, Whitsel L, Wilde P, O'Flaherty M, Micha R.

PLoS Med. 2018 Apr 10;15(4):e1002551. doi: 10.1371/journal.pmed.1002551. eCollection 2018 Apr.

19.

Systematic review of dietary trans-fat reduction interventions.

Hyseni L, Bromley H, Kypridemos C, O'Flaherty M, Lloyd-Williams F, Guzman-Castillo M, Pearson-Stuttard J, Capewell S.

Bull World Health Organ. 2017 Dec 1;95(12):821-830G. doi: 10.2471/BLT.16.189795. Epub 2017 Oct 19. Review.

20.

Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment.

Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M.

Lancet Diabetes Endocrinol. 2018 Feb;6(2):95-104. doi: 10.1016/S2213-8587(17)30366-2. Epub 2017 Nov 28. Corrected and republished in: Lancet Diabetes Endocrinol. 2018 Jun;6(6):e6-e15. Retraction in: Lancet Diabetes Endocrinol. 2018 Jun;6(6):437.

21.

The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities in the United States.

Peñalvo JL, Cudhea F, Micha R, Rehm CD, Afshin A, Whitsel L, Wilde P, Gaziano T, Pearson-Stuttard J, O'Flaherty M, Capewell S, Mozaffarian D.

BMC Med. 2017 Nov 27;15(1):208. doi: 10.1186/s12916-017-0971-9.

22.

Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: A modelling study.

Pearson-Stuttard J, Bandosz P, Rehm CD, Penalvo J, Whitsel L, Gaziano T, Conrad Z, Wilde P, Micha R, Lloyd-Williams F, Capewell S, Mozaffarian D, O'Flaherty M.

PLoS Med. 2017 Jun 6;14(6):e1002311. doi: 10.1371/journal.pmed.1002311. eCollection 2017 Jun.

23.

Comparing effectiveness of mass media campaigns with price reductions targeting fruit and vegetable intake on US cardiovascular disease mortality and race disparities.

Pearson-Stuttard J, Bandosz P, Rehm CD, Afshin A, Peñalvo JL, Whitsel L, Danaei G, Micha R, Gaziano T, Lloyd-Williams F, Capewell S, Mozaffarian D, O'Flaherty M.

Am J Clin Nutr. 2017 Jul;106(1):199-206. doi: 10.3945/ajcn.116.143925. Epub 2017 May 31.

24.

Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study.

Pearson-Stuttard J, Hooton W, Critchley J, Capewell S, Collins M, Mason H, Guzman-Castillo M, O'Flaherty M.

J Public Health (Oxf). 2017 Sep 1;39(3):574-582. doi: 10.1093/pubmed/fdw095.

PMID:
27613767
25.

Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.

d'Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J, Frangou E, Farmer AJ, Mant D, Wilson J, Myerson SG, Prendergast BD.

Eur Heart J. 2016 Dec 14;37(47):3515-3522. doi: 10.1093/eurheartj/ehw229. Epub 2016 Jun 26.

26.

Modeling Future Cardiovascular Disease Mortality in the United States: National Trends and Racial and Ethnic Disparities.

Pearson-Stuttard J, Guzman-Castillo M, Penalvo JL, Rehm CD, Afshin A, Danaei G, Kypridemos C, Gaziano T, Mozaffarian D, Capewell S, O'Flaherty M.

Circulation. 2016 Mar 8;133(10):967-78. doi: 10.1161/CIRCULATIONAHA.115.019904. Epub 2016 Feb 4.

27.

Recognition of the deteriorating patient.

Spiers L, Singh Mohal J, Pearson-Stuttard J, Greenlee H, Carmichael J, Busher R.

BMJ Qual Improv Rep. 2015 Mar 25;4(1). pii: u206777.w2734. doi: 10.1136/bmjquality.u206777.w2734. eCollection 2015.

28.

Diabetes and infection: assessing the association with glycaemic control in population-based studies.

Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J.

Lancet Diabetes Endocrinol. 2016 Feb;4(2):148-58. doi: 10.1016/S2213-8587(15)00379-4. Epub 2015 Dec 3. Review.

PMID:
26656292
29.

Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.

Allen K, Pearson-Stuttard J, Hooton W, Diggle P, Capewell S, O'Flaherty M.

BMJ. 2015 Sep 15;351:h4583. doi: 10.1136/bmj.h4583.

30.

CVD Prevention Through Policy: a Review of Mass Media, Food/Menu Labeling, Taxation/Subsidies, Built Environment, School Procurement, Worksite Wellness, and Marketing Standards to Improve Diet.

Afshin A, Penalvo J, Del Gobbo L, Kashaf M, Micha R, Morrish K, Pearson-Stuttard J, Rehm C, Shangguan S, Smith JD, Mozaffarian D.

Curr Cardiol Rep. 2015 Nov;17(11):98. doi: 10.1007/s11886-015-0658-9. Review.

31.

Quantifying the Socio-Economic Benefits of Reducing Industrial Dietary Trans Fats: Modelling Study.

Pearson-Stuttard J, Critchley J, Capewell S, O'Flaherty M.

PLoS One. 2015 Aug 6;10(8):e0132524. doi: 10.1371/journal.pone.0132524. eCollection 2015.

32.

Recent UK trends in the unequal burden of coronary heart disease.

Pearson-Stuttard J, Bajekal M, Scholes S, O'Flaherty M, Hawkins NM, Raine R, Capewell S.

Heart. 2012 Nov;98(21):1573-82. doi: 10.1136/heartjnl-2012-302435. Epub 2012 Aug 11.

PMID:
22888164

Supplemental Content

Loading ...
Support Center